LATORYA MOORE: Open Payments
NPI 1720593908 · SMITHFIELD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 19 payments from 10 companies in 2025. Trend: 2023 $3,700 · 2024 $308 · 2025 $495
Food & beverage: $356Education: $139
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $105 |
| Gilead Sciences, Inc. | 1 | $96 |
| E.R. Squibb & Sons, L.L.C. | 4 | $66 |
| SOBI, INC | 2 | $56 |
| Celgene Corporation | 3 | $50 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| Astellas Pharma US Inc | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $21 |
| Eisai Inc. | 1 | $19 |
Products named: Trodelvy, OPDIVO, ENHERTU, Vonjo, REBLOZYL, LYNPARZA, KEYTRUDA, Xospata.
Industry payments across NC — which companies pay providers there.
